In addition to IL-17, the other Th17 pathway cytokine IL-23 has been intensively investigated, given its critical role in activating Th17 cells,24 up-regulation of IL-23 in human uveitis,25 and well-demonstrated therapeutic effects of inhibiting IL-23 in EAU.26 This evidence concerns the gene IL17A and uveitis.